chr15-52124617-G-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_016194.4(GNB5):c.1032C>A(p.Tyr344*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,461,628 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000034 ( 0 hom. )
Consequence
GNB5
NM_016194.4 stop_gained
NM_016194.4 stop_gained
Scores
3
3
1
Clinical Significance
Conservation
PhyloP100: 2.59
Genes affected
GNB5 (HGNC:4401): (G protein subunit beta 5) Heterotrimeric guanine nucleotide-binding proteins (G proteins), which integrate signals between receptors and effector proteins, are composed of an alpha, a beta, and a gamma subunit. These subunits are encoded by families of related genes. This gene encodes a beta subunit. Beta subunits are important regulators of alpha subunits, as well as of certain signal transduction receptors and effectors. Alternatively spliced transcript variants encoding different isoforms exist. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most 50 bp of the penultimate exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.131 CDS is truncated, and there are 1 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 15-52124617-G-T is Pathogenic according to our data. Variant chr15-52124617-G-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 450608.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GNB5 | NM_016194.4 | c.1032C>A | p.Tyr344* | stop_gained | 12/13 | ENST00000261837.12 | NP_057278.2 | |
GNB5 | NM_006578.4 | c.906C>A | p.Tyr302* | stop_gained | 10/11 | NP_006569.1 | ||
GNB5 | NM_001379343.1 | c.750C>A | p.Tyr250* | stop_gained | 10/11 | NP_001366272.1 | ||
GNB5 | XM_011521162.4 | c.906C>A | p.Tyr302* | stop_gained | 10/11 | XP_011519464.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GNB5 | ENST00000261837.12 | c.1032C>A | p.Tyr344* | stop_gained | 12/13 | 5 | NM_016194.4 | ENSP00000261837.7 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251104Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135694
GnomAD3 exomes
AF:
AC:
1
AN:
251104
Hom.:
AF XY:
AC XY:
1
AN XY:
135694
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461628Hom.: 0 Cov.: 30 AF XY: 0.00000688 AC XY: 5AN XY: 727110
GnomAD4 exome
AF:
AC:
5
AN:
1461628
Hom.:
Cov.:
30
AF XY:
AC XY:
5
AN XY:
727110
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Bravo
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Gnb5-related intellectual disability-cardiac arrhythmia syndrome Pathogenic:2Other:1
not provided, no classification provided | literature only | GeneReviews | - | Recurrent variant reported in 2 families from Pakistan; de novo in 1 family - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 17, 2023 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Centogene AG - the Rare Disease Company | - | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 25, 2017 | The c.1032 C>A nucleotide substitution, resulting in the Y344X variant in the GNB5 gene, has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. However, a different nucleotide substitution (c.1032 C>G) that also results in the Y344X variant, denoted as c.906 C>G and Y320X due to alternative nomenclature, was reported previously as homozygous in an Indian child with severe intellectual disability, absent speech, epilepsy, hypotonia, gastric reflux, nystagmus, and severe sick sinus syndrome (Lodder et al., 2016). The Y344X variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The Y344X variant due to the c.1032 C>A substitution is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). We interpret Y344X as a pathogenic variant. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
MutationTaster
Benign
A;A;A
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at